Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Morgan Stanley (MS)

NYSE: MS · Investment Banking & Brokerage · New York, NY

Our rating: Positive

Positive reaffirmed at $181.44, moderate conviction, November 6, 2026.

Breaks if: The Positive call rests on ROE staying comfortably above cost of equity and the wealth management revenue stream holding its trajectory. It is proven wrong if ROE falls to or below 12% across two consecutive quarterly filings — signaling the premium multiple is no longer supported by returns — or if the stock drops more than 20% from today's $181.44 within the next twelve months without a corresponding downward revision in consensus earnings estimates that would re-open a valuation gap.

Key figures

Market value$258.9B
Revenue, last 12 months$80.2B
Net income, last 12 months$20.5B
Free cash flow, last 12 monthsn/a
Price to earnings12.7×
Free cash flow yieldn/a
Dividend yield2.6%
Operating marginn/a
Return on equity18.0%
Beta to the S&P 5001.34
Volatility, annualized30.1%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$20.3B11.6%$3.03n/a
June 30, 2026$21.3B27.1%$3.46n/a
March 31, 2026$20.6B16.0%$3.43n/a
December 31, 2025$17.9B10.3%$2.68n/a
September 30, 2025$18.2B18.5%$2.80n/a
June 30, 2025$16.8B11.8%$2.13n/a
March 31, 2025$17.7B17.2%$2.60n/a
December 31, 2024$16.2B25.8%$2.22n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

15 ledger entries and 0 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.